본문 바로가기

Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q2
피인용
Web of Science 27
JCR IF
JCR 2011 1.757
ISSN
0954-691X

저자

  1. 전혜경제1저자부산대학교, 부산대학교병원, 대학병원, KO
  2. 김동욱A교신저자부산대학교, 의과대학, 의학과, KO
  3. 백동훈부산대학교, 부산대학교병원, 대학병원, KO
  4. 하동우부산대학교, Dept Internal Med, KO
  5. 이봉은부산대학교, 의과대학, 의학과, KO
  6. 류동엽부산대학교, 부산대학교병원, 대학병원, KO
  7. 정재훈부산대학교, 부산대학교병원, 대학병원, KO
  8. 김광하부산대학교, 의과대학, 의과학과, KO
  9. 송근암부산대학교, 의과대학, 의학과, KO
  10. 장애리부산대학교, 간호대학, 간호학과, KO

초록

Background A high incidence of venous thromboembolism (VTE) has been observed in patients with cancer. However, few data are available on patients with cholangiocarcinoma. Objectives The aim of this study was to evaluate the clinical characteristics and risk factors of VTE and to investigate whether VTE would affect the survival of patients with cholangiocarcinoma. Methods We retrospectively reviewed 273 patients who were diagnosed with cholangiocarcinoma from January 2004 to December 2008. Results We observed 40 cases of VTE, among which 10 patients had VTE at diagnosis. There were 14 cases of pulmonary thromboembolism with or without deep vein thrombosis, 18 cases of portal vein thrombosis, four cases of inferior vena cava thrombosis, and four of hepatic vein thrombosis. We found that progression of stage, C-reactive protein, and chemotherapy were significantly associated with the occurrence of VTE (P = 0.022, 0.006, and 0.014, respectively). The median survival in the VTE and non-VTE groups were 13.0 and 25.0 months, respectively (log-rank test, P = 0.026). VTE was an unfavorable prognostic factor for cholangiocarcinoma (hazard ratio = 1.626, P = 0.042). Conclusion In our study, advanced stage, C-reactive protein, and treatment with chemotherapeutic agents were related to the occurrence of VTE in patients with cholangiocarcinoma. VTE was an independent unfavorable prognostic factor for survivors of cholangiocarcinoma. Eur J Gastroenterol Hepatol 24: 444-449 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

키워드

cholangiocarcinomarisk factorsurvivalvenous thromboembolismTROUSSEAUS-SYNDROMECANCER-PATIENTSCHEMOTHERAPYTHROMBOSISADENOCARCINOMACISPLATIN

식별자

WoS UID
000301288700015